chr5-37294341-C-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_153485.3(NUP155):āc.3918G>Cā(p.Leu1306Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000279 in 1,434,462 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: not found (cov: 31)
Exomes š: 0.0000028 ( 0 hom. )
Consequence
NUP155
NM_153485.3 missense
NM_153485.3 missense
Scores
4
14
1
Clinical Significance
Conservation
PhyloP100: 1.53
Genes affected
NUP155 (HGNC:8063): (nucleoporin 155) Nucleoporins are proteins that play an important role in the assembly and functioning of the nuclear pore complex (NPC) which regulates the movement of macromolecules across the nuclear envelope (NE). The protein encoded by this gene plays a role in the fusion of NE vesicles and formation of the double membrane NE. The protein may also be involved in cardiac physiology and may be associated with the pathogenesis of atrial fibrillation. Alternative splicing results in multiple transcript variants of this gene. A pseudogene associated with this gene is located on chromosome 6. [provided by RefSeq, May 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.846
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NUP155 | NM_153485.3 | c.3918G>C | p.Leu1306Phe | missense_variant | 33/35 | ENST00000231498.8 | NP_705618.1 | |
NUP155 | NM_004298.4 | c.3741G>C | p.Leu1247Phe | missense_variant | 33/35 | NP_004289.1 | ||
NUP155 | NM_001278312.2 | c.3726G>C | p.Leu1242Phe | missense_variant | 32/34 | NP_001265241.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NUP155 | ENST00000231498.8 | c.3918G>C | p.Leu1306Phe | missense_variant | 33/35 | 1 | NM_153485.3 | ENSP00000231498.3 | ||
NUP155 | ENST00000381843.6 | c.3741G>C | p.Leu1247Phe | missense_variant | 33/35 | 1 | ENSP00000371265.2 | |||
NUP155 | ENST00000513532.1 | c.3726G>C | p.Leu1242Phe | missense_variant | 32/34 | 1 | ENSP00000422019.1 | |||
NUP155 | ENST00000502533.5 | n.1576G>C | non_coding_transcript_exon_variant | 12/14 | 5 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 genomes
Cov.:
31
GnomAD3 exomes AF: 0.0000164 AC: 4AN: 243580Hom.: 0 AF XY: 0.00000760 AC XY: 1AN XY: 131654
GnomAD3 exomes
AF:
AC:
4
AN:
243580
Hom.:
AF XY:
AC XY:
1
AN XY:
131654
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000279 AC: 4AN: 1434462Hom.: 0 Cov.: 27 AF XY: 0.00000140 AC XY: 1AN XY: 714716
GnomAD4 exome
AF:
AC:
4
AN:
1434462
Hom.:
Cov.:
27
AF XY:
AC XY:
1
AN XY:
714716
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 31
GnomAD4 genome
Cov.:
31
ExAC
AF:
AC:
2
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 17, 2021 | The c.3918G>C (p.L1306F) alteration is located in exon 33 (coding exon 33) of the NUP155 gene. This alteration results from a G to C substitution at nucleotide position 3918, causing the leucine (L) at amino acid position 1306 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Benign
DANN
Uncertain
DEOGEN2
Uncertain
D;.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D;D
MetaSVM
Uncertain
T
MutationAssessor
Uncertain
M;.;.
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;D
REVEL
Pathogenic
Sift
Uncertain
D;D;D
Sift4G
Uncertain
D;D;D
Polyphen
D;.;D
Vest4
MutPred
Loss of stability (P = 0.0838);.;.;
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at